Shire Plc - Overview

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

Competitors: GSK, Glaxosmithkline Plc, AstraZeneca
Registrars:

Key Personnel

CEO: Flemming Ornskov
CFO: Thomas Dittrich
Chairman: Susan Kilsby
Non-Executive Director: Steven Gillis, Gail D. Fosler , Albert P.L. Stroucken , Ian Clark, David Ginsburg, Sara Mathew
Senior Independent Director: Olivier Bohuon

Contact Details

Address: 22 Grenville Street, St Helier, Jersey
Phone: +44 (0) 1256 894 000
Fax: +44 (0) 1256 894 708
Website: http://www.shire.com
Email:

Listings

ISIN: JE00B2QKY057